Indicaid® Rapid Antigen Test

The INDICAID^® COVID-19 Rapid Antigen Test is a lateral flow immunoassay designed for the objective identification of SARS-CoV-2 antigens. Antigen tests are designed to detect proteins from the virus that causes COVID-19 through swab specimens taken from a patient’s nose.

INDICAID^® Point-of-Care (PoC) professional is a reliable indicator for COVID-19 in the laboratory, office, attended events & more.

Batch-collection & bulk-testing of individual samples

With the intuitive vial design, INDICAID^® PoC (Point-of-Care) Professional Rapid Antigen Tests allow for the aggregate collection of multiple specimens followed by batch-testing of individual samples up to two (2) hours after collection, in the laboratory setting.

Product Specifications

Additional Information

This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.